Ann Warner, MD
Rheumatology · Kansas City, MONPI 1750343455
Payments from drug & device makers
What this record shows
This record is dominated by education: $37 of the $55 with a category attached, or 66.9%. Pfizer accounts for 66.9% of it on its own, with 1 other manufacturer making up the rest. That places this record below the midpoint for rheumatology clinicians in MO, where the typical reported total is $1,657.
Across 2 payments — averaging $27.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$37
- Sobi, Inc$18
Across 2 payments — averaging $651.88 each. An ownership or investment interest held by the physician or an immediate family member.
- Consortium Of Independent Immunology Clinics, LLC$1K
What the payments were for
- Food & beverage$1833%
- Education$3767%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$55 in reported general payments places this provider in the 5th percentile of 134 rheumatology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xeljanz XrTofacitinib Citrate | 90 | $577,655 |
| Humira(Cf) PenAdalimumab | 66 | $494,435 |
| Enbrel SureclickEtanercept | 56 | $418,366 |
| Humira(Cf)Adalimumab | 42 | $322,345 |
| OrenciaAbatacept | 26 | $144,242 |
| Hydroxychloroquine Sulfate | 1,202 | $63,405 |
| ForteoTeriparatide | 12 | $59,890 |
| Leflunomide | 289 | $18,326 |
| MethotrexateMethotrexate Sodium | 414 | $15,202 |
| Mycophenolate Mofetil | 57 | $11,581 |
| Sulfasalazine DrSulfasalazine | 156 | $9,534 |
| Azathioprine | 89 | $6,343 |
| Sulfasalazine | 147 | $5,741 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 11 | $5,397 |
| Celecoxib | 198 | $5,073 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Kansas City
- Mark BoxKansas City$304K
- Ghaith NoaisehKansas City$69K
- Thomas ScottKansas City$48K
- Tina ShahKansas City$36K
- David JohnKansas City$3K
- Julian MagadanKansas City$3K
- Anne WinklerCarthage$1.6M
- Adam KilianSaint Louis$565K
- Alfred KimSaint Louis$486K
- Sona KamatSaint Louis$268K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.